Ian George
Chief Scientific Officer @ New Wave Ventures
Upper Heyford, United Kingdom
Ian George is a Series A investor at New Wave Ventures in Upper Heyford focused on Medical and Health Care. Ian is a founder director of Enigma Diagnostics and is responsible for the company's business development & IP functions. Previously he worked as a Business Consultant at The Technology Partnership and prior to that, he was a Business Development Manager at the Defence Science Technology Laboratory where he was responsible for thecommercialisation of healthcare technology and the formation of several spin-out companies including Enigma and P2i Ltd.Earlier in his career Ian worked in technology commercialisation for Unilever Research and Sequa Corp. Ian is a non-executive director of Discuva and Cambridge Scientific Innovations, two New Wave Ventures portfolio companies. Ian lives in Wiltshire. After a period serving as a member of New Wave’s Advisory Board, Ian was appointed CSO in October 2013.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Ian George invests in
Stages Ian George invests in
Countries Ian George invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Medical 1 (100%)
- Health Care 1 (100%)
- Information Technology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xerion Healthcare
|
Xerion Healthcare develop nanoparticles that are used to improve treatment of cancer. The nanoparticles are injected into tumours just prior to standard radiotherapy and act to enhance the effectiveness of the treatment, amplifying the dose of free radicals generated by the X-rays. The nanoparticles are based on titanium dioxide, a common,non-toxic, semiconductor material. Xerion Healthcare are currently developing the treatment for head and neck and pancreatic tumours. | $2M / Series A / Sep 04, 2015 |
About New Wave Ventures
New Wave Ventures is a privately owned fund seeking the opportunity to invest for the long term in companies with significant growth potential. Their target initial investment is £500,000 to £2,000,000. They invest their own money without the need for external investors or borrowings. They are not driven by the need to service interest charges orto dispose of their investments by an artificial deadline. They do not believe in using leverage to boost their returns. They are willing to co-invest with like-minded investors, although their preference is to be the sole investor alongside owner-managers.
New Wave Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Clare Twemlow
Chief Financial Officer
|
|||
|
Ian George
Chief Scientific Officer
|
|||
Paul Newey
Co-Founder
|
|||
Tim Bullock
Co-Founder
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Ian George invest in?
Ian George invests primarily in Medical, Health Care and Information Technology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Ian George?
Public channels for Ian George include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Ian George last invest?
The most recent investment recorded for Ian George closed in Sep 2015. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
